HR 6839, the Vaccine Transportation Access Act, provides federal grants to nonprofit community organizations that serve low-income or minority communities facing transportation barriers to vaccines. The grants fund projects like on-demand rides, first/last mile transportation to vaccine sites, and expanded transit coordination to reduce missed appointments. Recipients must track performance metrics and report outcomes to the Department of Health and Human Services. The bill also adds a provision ensuring 100% federal funding for nonemergency vaccine-related transportation costs under Medicaid plans.
The EPIC Act of 2025 extends the required time period for negotiating drug prices under the federal program for biologic drugs. It changes the rule so that biologic drug manufacturers must wait at least 11 years after FDA approval before their drug can be included in price negotiations, starting with the 2028 initial price applicability year. This specifically affects biologic drug manufacturers, as the change applies only to biologics (not small-molecule drugs, which already have different rules). The bill modifies Section 1192(e)(1)(A)(ii) of the Social Security Act to implement this longer waiting period. This is a concrete policy change to the timing of drug price negotiations, not a new program or broader policy shift.
HR 4074, the Optimizing Postpartum Outcomes Act of 2025, requires the Health and Human Services Secretary to issue guidance within one year on improving Medicaid and CHIP coverage for pelvic health services during pregnancy and the postpartum period (defined as up to 6 months after birth or during lactation). The bill directs the GAO to study coverage gaps for these services and mandates a new CDC-led education campaign to train healthcare providers and inform postpartum women about pelvic floor exams and physical therapy. Key provisions include standardizing terminology for pelvic health conditions, sharing state best practices for payment models, and authorizing $2 million annually for the education program through 2030. This bill directly affects postpartum women covered by Medicaid or CHIP by aiming to increase access to evidence-based pelvic health care.
HR 3019, the Holding Nonprofit Hospitals Accountable Act, requires nonprofit hospitals receiving tax exemptions to meet new community benefit standards. It mandates these hospitals to have community-elected boards, treat patients using public programs (like Medicare/Medicaid) without limiting numbers, and spend at least 100% of their annual tax exemptions on specific community services - including patient care training, facility upgrades, and free/discounted care. The bill also requires hospitals to follow Medicare billing rates for financial assistance and establishes annual reviews by the Treasury Inspector General and GAO to monitor compliance and enforcement. These changes apply to taxable years beginning after December 31, 2025, directly affecting nonprofit hospitals that operate under IRS 501(c)(3) status.
The FORCE Act of 2025 allows eligible first responders to enroll in Medicare at age 57 instead of the standard 65. To qualify, individuals must be between 57 and 64 years old, have worked 10+ years in specific first responder occupations (identified by Bureau of Labor Statistics codes like 33-1010 or 33-2000), and not yet qualify for standard Medicare at age 65. The bill establishes a new Medicare benefit section with premiums based on standard Part B/A costs, funded through a dedicated "Medicare First Responder Trust Fund." It ensures these enrollees receive full Medicare benefits, including prescription drug coverage, without affecting existing Medicare or Medicaid eligibility.
The PBM Reform Act of 2025 aims to increase transparency and fairness in pharmacy benefit manager (PBM) operations within Medicare Part D and Medicaid programs. The bill requires Medicare Part D plans to allow any pharmacy meeting standard terms to join their networks, establishes "essential retail pharmacies" in underserved areas (with limited pharmacy access), and mandates detailed reporting on drug pricing, rebates, and reimbursement rates. It creates a process for pharmacies to report PBM violations of reasonable contract terms and prohibits "spread pricing" in Medicaid, where PBMs retain the difference between what they pay pharmacies and what they charge plans. These provisions aim to improve pharmacy access for Medicare beneficiaries and ensure fairer reimbursement practices for pharmacies.
The BABIES Act (HR 5202) provides federal grants and Medicaid demonstration programs to expand access to freestanding birth centers, primarily benefiting low-risk pregnant women in underserved areas who rely on Medicaid. It allocates $5 million (2026-2030) for grants up to $500,000 per birth center to cover facility upgrades, equipment, and accreditation costs, with priority for centers in maternity care deserts or areas with poor outcomes. Additionally, it creates a 4-year Medicaid demonstration program testing new payment models for birth centers that meet strict standards (like accreditation, licensure, and emergency capabilities), requiring states to develop prospective payment systems covering services from pregnancy through postpartum care. The program aims to improve access and quality of low-risk maternity care while collecting data on clinical outcomes and costs compared to traditional hospital services.
Increasing Access to Lung Cancer Screening Act This bill provides for coverage without prior authorization requirements of annual lung cancer screenings under Medicaid, Medicare, and private health insurance for individuals for whom screenings are recommended under U.S. Preventive Services Task Force guidelines. It also expands Medicaid coverage of counseling and pharmacotherapy for cessation of tobacco use to all individuals, rather than only pregnant women. The Department of Health and Human Services must conduct outreach on the importance of lung cancer screenings and who should be screened, and the Government Accountability Office must report on the demographics of those diagnosed with lung cancer and recommend ways the federal government can improve screenings.
This bill modifies Medicare's physician self-referral rules to improve access for rural communities. It creates a new exemption for "covered rural hospitals" (defined as facilities in rural areas more than 35 miles from another hospital or critical access hospital) from certain restrictions on physicians owning hospitals. The bill also removes a prohibition on expanding existing physician-owned hospitals, allowing such expansions after the law's enactment. These changes directly affect rural hospitals seeking Medicare participation and physicians who own or operate hospitals in underserved areas.
This bill amends the Social Security Act to increase Medicaid payment limits for the Northern Mariana Islands. It directly affects the Northern Mariana Islands' Medicaid program by setting its 2026 payment amount equal to the amount allocated to American Samoa for that same fiscal year. The key provision modifies Section 1108(g)(2)(D) to add a new clause specifying this alignment for fiscal year 2026. This changes the funding formula for the territory's Medicaid program without creating new benefits or eligibility rules. The adjustment applies only to the payment limit calculation for the Northern Mariana Islands' Medicaid program.